UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
First Solar
FSLR
$25.4B
| $4.94M | ﹤0.01% |
110,675
-4,134
| -4% | -$211K |
|
1002
Cadence Design Systems
CDNS
$92.8B
| $4.9M | ﹤0.01% |
258,103
+6,979
| +3% | +$125K |
|
|
CLC
1003
DELISTED
Clarcor
CLC
| $4.85M | ﹤0.01% |
72,825
+3,203
| +5% | +$208K |
|
1004
Rio Tinto
RIO
$165B
| $4.81M | ﹤0.01% |
104,486
-29,872
| -22% | -$1.41M |
|
|
GTLS
1005
DELISTED
Chart Industries
GTLS
| $4.8M | ﹤0.01% |
140,254
-4,058
| -3% | -$170K |
|
1006
Gartner
IT
$12.5B
| $4.8M | ﹤0.01% |
56,959
+1,800
| +3% | +$146K |
|
|
WCN
1007
Waste Connections
WCN
$41.5B
| $4.79M | ﹤0.01% |
163,268
-69,300
| -30% | -$2.18M |
|
1008
America Movil
AMX
$72.1B
| $4.78M | ﹤0.01% |
215,400
-8,000
| -4% | -$186K |
|
|
BDN
1009
Brandywine Realty Trust
BDN
$551M
| $4.78M | ﹤0.01% |
298,886
+30,100
| +11% | +$457K |
|
|
CYN
1010
DELISTED
CITY NATIONAL CORPORATION
CYN
| $4.65M | ﹤0.01% |
57,588
-1,838
| -3% | -$142K |
|
1011
iShares International Developed Real Estate ETF
IFGL
$83.1M
| $4.63M | ﹤0.01% |
154,164
+34,223
| +29% | +$1.04M |
|
1012
Norwegian Cruise Line
NCLH
$9.32B
| $4.62M | ﹤0.01% |
+98,808
| New | +$3.97M |
|
1013
Pebblebrook Hotel Trust
PEB
$2.15B
| $4.61M | ﹤0.01% |
101,066
+12,768
| +14% | +$535K |
|
1014
Diamondrock Hospitality Co
DRH
$2.71B
| $4.58M | ﹤0.01% |
308,042
+17,252
| +6% | +$245K |
|
1015
Idexx Laboratories
IDXX
$46.1B
| $4.55M | ﹤0.01% |
61,324
+1,600
| +3% | +$112K |
|
1016
Hope Bancorp
HOPE
$1.82B
| $4.51M | ﹤0.01% |
313,461
+42,731
| +16% | +$604K |
|
1017
Keysight
KEYS
$57.4B
| $4.49M | ﹤0.01% |
+132,949
| New | +$4.34M |
|
|
GRA
1018
DELISTED
W.R. Grace & Co.
GRA
| $4.48M | ﹤0.01% |
46,944
+1,900
| +4% | +$177K |
|
1019
Alaska Air
ALK
$5.81B
| $4.47M | ﹤0.01% |
74,750
-14,250
| -16% | -$751K |
|
|
BEL
1020
DELISTED
Belmond Ltd.
BEL
| $4.45M | ﹤0.01% |
359,297
-40,700
| -10% | -$464K |
|
1021
Rigel Pharmaceuticals
RIGL
$749M
| $4.44M | ﹤0.01% |
195,430
-3,210
| -2% | -$64.9K |
|
|
XLRN
1022
DELISTED
Acceleron Pharma
XLRN
| $4.42M | ﹤0.01% |
113,400
-2,300
| -2% | -$80.2K |
|
|
FEIC
1023
DELISTED
FEI COMPANY
FEIC
| $4.42M | ﹤0.01% |
48,899
-89,300
| -65% | -$7.45M |
|
|
GEVA
1024
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $4.42M | ﹤0.01% |
47,600
-100
| -0.2% | -$7.89K |
|
|
CBST
1025
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $4.38M | ﹤0.01% |
43,503
-168,800
| -80% | -$13.1M |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.